LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 658 | 632 | 3761 | 0.1681 | -0.0170 |
Hs 578T | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 658 | 848 | 3761 | 0.2256 | 0.1060 |
Hs 578T | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 658 | 2831 | 3761 | 0.7524 | 0.7857 |
Hs 578T | AZD7762 | 0.12 | uM | LJP6 | 72 | hr | 658 | 968 | 3761 | 0.2572 | 0.1635 |
Hs 578T | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 658 | 1200 | 3761 | 0.3192 | 0.2698 |
Hs 578T | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 658 | 910 | 3761 | 0.2420 | 0.1372 |
Hs 578T | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3790 | 3933 | 0.9635 | 0.9713 |
Hs 578T | Seliciclib | 10 | uM | LJP5 | 72 | hr | 658 | 2298 | 3933 | 0.5845 | 0.6238 |
Hs 578T | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 658 | 442 | 3761 | 0.1175 | -0.1466 |
Hs 578T | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 658 | 2131 | 3761 | 0.5665 | 0.5953 |
Hs 578T | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 658 | 272 | 3761 | 0.0723 | -0.2965 |
Hs 578T | AZD7762 | 10 | uM | LJP6 | 72 | hr | 658 | 203 | 3761 | 0.0542 | -0.3743 |
Hs 578T | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 658 | 1002 | 3761 | 0.2665 | 0.1819 |
Hs 578T | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 658 | 939 | 3761 | 0.2496 | 0.1512 |
Hs 578T | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 658 | 4001 | 3933 | 1.0171 | 1.0130 |
Hs 578T | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3900 | 3933 | 0.9916 | 0.9933 |
Hs 578T | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 658 | 3525 | 3933 | 0.8962 | 0.9168 |
Hs 578T | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3388 | 3933 | 0.8615 | 0.8877 |
Hs 578T | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 658 | 897 | 3761 | 0.2387 | 0.1311 |
Hs 578T | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 658 | 423 | 3761 | 0.1127 | -0.1611 |
Hs 578T | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 658 | 341 | 3761 | 0.0908 | -0.2312 |
Hs 578T | AT-7519 | 10 | uM | LJP6 | 72 | hr | 658 | 304 | 3761 | 0.0811 | -0.2642 |
Hs 578T | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 658 | 398 | 3761 | 0.1060 | -0.1812 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3967 | 3761 | 1.0550 | 1.0430 |
Hs 578T | AZD8055 | 10 | uM | LJP6 | 72 | hr | 658 | 103 | 3761 | 0.0276 | -0.5223 |